AMEX : IGC

IGC Pharma, Inc.

$0.26 USD

$0.0 (1.44%)

Volume
235.05K
Average Volume
1.27M
Market Capitalization
$26.02M
P/E Ratio
-3.60
Dividend Yield
0.00%
Price Target
Year High
$0.50
Year Low
$0.24
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$0.40
3333332"{? p/.m7yd f,0=

Annual earnings financials

IGC financial data with annual/quarterly toggle

IGC GAAP EPS - Annual & Quarterly

IGC Sales Revenue - Annual & Quarterly

IGC Shares Outstanding - Annual & Quarterly

Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.

IGC Estimated and Actual Revenue by Quarter
IGC Estimated and Actual EPS by Quarter
IGC Analyst Forecasts — EBITDA & EBIT
Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2027-12-31 1 -280K -280K -280K -280K -280K -280K
2027-09-30 1 -96000 -96000 -96000 -96000 -96000 -96000
2027-06-30 1 -164K -164K -164K -164K -164K -164K
2027-03-31 1 -317K -317K -317K -317K -317K -317K
2026-12-31 1 -280K -280K -280K -280K -280K -280K
2026-09-30 1 -96000 -96000 -96000 -96000 -96000 -96000
IGC Analyst Forecasts — Net Income & SGA Expense
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2027-12-31 1 -1.9M -1.9M -1.9M 3.09M 3.09M 3.09M
2027-09-30 1 -1.9M -1.9M -1.9M 1.06M 1.06M 1.06M
2027-06-30 1 -1.9M -1.9M -1.9M 1.81M 1.81M 1.81M
2027-03-31 1 -1.9M -1.9M -1.9M 3.5M 3.5M 3.5M
2026-12-31 1 -1.9M -1.9M -1.9M 3.09M 3.09M 3.09M
2026-09-30 1 -1.9M -1.9M -1.9M 1.06M 1.06M 1.06M
IGC Analyst Forecasts — Revenue & EPS
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2027-12-31 1 280K 280K 280K 1 -0.02 -0.02 -0.02
2027-09-30 1 96000 96000 96000 1 -0.02 -0.02 -0.02
2027-06-30 1 164K 164K 164K 1 -0.02 -0.02 -0.02
2027-03-31 1 317K 317K 317K 1 -0.02 -0.02 -0.02
2026-12-31 1 280K 280K 280K 1 -0.02 -0.02 -0.02
2026-09-30 1 96000 96000 96000 1 -0.02 -0.02 -0.02